BLCO Stock Summary and Trading Ideas (Bausch & Lomb | NYSE:BLCO)

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Bausch & Lomb trades on the NYSE stock market under the symbol BLCO.

As of April 24, 2026, BLCO stock price climbed to $15.82 with 230,406 million shares trading.

BLCO has a beta of 1.31, meaning it tends to be more sensitive to market movements. BLCO has a correlation of 0.21 to the broad based SPY ETF.

BLCO has a market cap of $5.61 billion. This is considered a Mid Cap stock.

Last quarter Bausch & Lomb reported $1 billion in Revenue and $.32 earnings per share. This beat revenue expectation by $22 million and missed earnings estimates by -$.03.

In the last 3 years, BLCO traded as high as $21.95 and as low as $10.45.

The top ETF exchange traded funds that BLCO belongs to (by Net Assets): MGMT, DFAX, DFIC, GUSA.

BLCO has underperformed the market in the last year with a price return of +13.9% while the SPY ETF gained +31.9%. BLCO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -6.8% and -4.1%, respectively, while the SPY returned +3.8% and +5.1%, respectively.

BLCO support price is $15.39 and resistance is $16.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BLCO shares will trade within this expected range on the day.